|
KMID : 1030220120130010039
|
|
Journal of Korean Diabetes
2012 Volume.13 No. 1 p.39 ~ p.43
|
|
|
Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes
|
|
Yoo Hye-Jin
|
|
|
Abstract
|
|
|
|
A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring and effective intervention for postprandial hyperglycemia is very important in routine clinical practice for type 2 diabetes. Therapeutic modalities for the management of postprandial hyperglycemia include oral antidiabetic drugs (alpha glucosidase inhibitor, meglitinide, dipeptidyl peptidase-IV inhibitor), ultra-shortacting insulin analogues, and incretin mimetics. A detailed understanding of the advantages and disadvantages of various pharmacotherapies and a careful understanding of the underlying physical and social situations of each patient will be of great help to determine the appropriate prescription for postprandial hyperglycemia management.
|
|
|
KEYWORD
|
|
|
Hyperglycemia, Type 2 diabetes mellitus, Drug therapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|